Heart Failure Management

AI Will Improve Equity in Heart Failure Care: Con

by Prateek Chopra | June 3, 2026 | Cardiology Conferences | ESC-HF 2026 Artificial intelligence (AI) was examined as a technology that may unintentionally widen disparities in heart failure care rather than reduce them. Although AI offers opportunities for improved diagnosis, risk prediction, and treatment optimization, concerns were raised regarding unequal access to digital infrastructure, algorithmic bias, and underrepresentation of vulnerable […]

AI Will Improve Equity in Heart Failure Care: Con Read Post »

Leave a Comment / ESC-HF Day 4 / / / , , , ,

AI Will Improve Equity in Heart Failure Care: Pro

by Prateek Chopra | June 3, 2026 | Cardiology Conferences | ESC-HF 2026 Artificial intelligence (AI) was discussed as a promising approach to address inequities in heart failure care. Persistent disparities in diagnosis, treatment, and outcomes arise from differences in access to specialists, healthcare infrastructure, and adherence to evidence-based therapies. AI was presented as a tool capable of analyzing large volumes

AI Will Improve Equity in Heart Failure Care: Pro Read Post »

Leave a Comment / ESC-HF Day 4 / / / , , , ,

Heart Failure Unit: Spain’s Secret Weapon for GDMT Optimisation

by Prateek Chopra | June 2, 2026 | Cardiology Conferences | ESC-HF 2026 Heart failure (HF) remains a major global health burden despite the availability of highly effective guideline-directed medical therapies (GDMT). However, the greatest challenge is no longer the discovery of therapies, but the establishment of healthcare systems capable of delivering rapid, protocol-driven, and sustained optimization of treatment. The findings

Heart Failure Unit: Spain’s Secret Weapon for GDMT Optimisation Read Post »

Leave a Comment / ESC-HF Day 4 / / / , , , ,

A New Monitoring System for Heart Failure Patients

by Prateek Chopra | May 31, 2026 | Cardiology Conferences | ESC-HF 2026 Management of acute and chronic HF requires continuous monitoring, yet existing workflows using multiple systems were fragmented and time-consuming. To improve care coordination and support NICOR/National Heart Failure Audit requirements, a new HF pro forma was introduced to streamline monitoring and data collection. The project aimed to improve

A New Monitoring System for Heart Failure Patients Read Post »

Leave a Comment / ESC-HF Day 4 / / / , , ,

Are We Mee ng the Guidelines? A Review on Management of Heart FailurePa ents in a General Hospital in UK

by Prateek Chopra | May 30, 2026 | Cardiology Conferences | ESC-HF 2026 Heart failure (HF) remains associated with substantial mortality and morbidity despite advances in therapy. Guideline-directed medical therapy improves outcomes in heart failure with reduced ejection fraction (HFrEF); however, adherence in routine clinical practice remains variable. This study evaluated adherence to guideline-recommended diagnostic and therapeutic strategies among patients newly

Are We Mee ng the Guidelines? A Review on Management of Heart FailurePa ents in a General Hospital in UK Read Post »

Leave a Comment / ESC-HF Day 4 / / / , , , ,

How to Implement Digital Health Technologies in Pa ents with Heart Failure: A Comprehensive Approach

by Prateek Chopra | May 30, 2026 | Cardiology Conferences | ESC-HF 2026 Heart failure management spans screening, diagnosis, treatment, and monitoring, with digital tools supporting improved outcomes and reduced hospitalizations. The PORTHOS study highlighted marked underdiagnosis of HF, particularly HFpEF, with prevalence increasing with age and being higher in women. A comprehensive approach to implementing digital health technologies in patients

How to Implement Digital Health Technologies in Pa ents with Heart Failure: A Comprehensive Approach Read Post »

Leave a Comment / ESC-HF Day 4 / / / , , , ,

Door-to-GDMT Time: The Effect of De Novo Diagnosis of Heart Failure on Guideline-directed Medical Therapy Optimisation During the Rapid-up Titration Programme and on Prognosis

by Prateek Chopra | May 27, 2026 | Cardiology Conferences | ESC-HF 2026 Early initiation of guideline-directed medical therapy (GDMT) has shown significant prognostic benefits in heart failure (HF). Despite strong evidence for life-saving drug therapy, previous real-world registries of chronic HF patients have consistently revealed low prescription rates and underdosing of GDMT. Accordingly, the 2023 ESC HF guidelines recommend rapid

Door-to-GDMT Time: The Effect of De Novo Diagnosis of Heart Failure on Guideline-directed Medical Therapy Optimisation During the Rapid-up Titration Programme and on Prognosis Read Post »

Leave a Comment / ESC-HF Day 3 / / / , , , ,

Opmizing Heart Failure Treatment in Pa ents Receiving Renal ReplacementTherapy: The Role of a Cardiorenal Unit

by Prateek Chopra | May 17, 2026 | Cardiology Conferences | ESC-HF 2026 Cardiorenal syndrome (CRS) remains a major therapeutic challenge, particularly in patients receiving renal replacement therapy, where evidence supporting guideline-directed Heart Failure (HF) therapies is limited. The management of these patients is often complicated by multiple comorbidities, fluid overload, and concerns regarding treatment tolerability and safety. This study aimed

Opmizing Heart Failure Treatment in Pa ents Receiving Renal ReplacementTherapy: The Role of a Cardiorenal Unit Read Post »

Leave a Comment / ESC-HF Day 1 / / / , , , ,
Scroll to Top